Serum-free media for the production of human mesenchymal stromal cells: A review

Cell Proliferation

Volumn 46, Issue 6, 2013, Pages 608-627

  Gottipamula, S ^a   Muttigi, M S ^a   Kolkundkar, U ^b   Seetharam, R N ^a  

^a KASTURBA HOSPITAL   (India)

^b Akshay Tech Park   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PLACENTA LACTOGEN;

ARTICLE; BRAIN SPONGIOSIS; CELL LYSATE; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; COMPARATIVE GENOMIC HYBRIDIZATION; CULTURE MEDIUM; HUMAN; LARGE SCALE PRODUCTION; MESENCHYMAL STROMA CELL; SERUM FREE MEDIA; STEM CELL EXPANSION; SUPPLEMENTATION;

BOVINAE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84886749781     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12063     Document Type: Article

References (111)

1. Prockop DJ (2007) "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. 82, 241-243.
2. Le Blanc K (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5, 485-489.
3. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57, 11-20.
4. Subbanna PK (2007) Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose. Med. Hypotheses 69, 469-470.
5. Sensebé L, Bourin P (2009) Mesenchymal stem cells for therapeutic purposes. Transplantation 87, S49-S53.
6. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H et al. (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115, 1549-1553.
7. Phinney DG, Sensebe L (2013) Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy 15, 140-145.
8. Gstraunthaler G (2003) Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20, 275-281.
9. Levings RL, Wessman SJ (1991) Bovine viral diarrhea virus contamination of nutrient serum, cell cultures and viral vaccines. Dev. Biol. Stand. 75, 177-181.
10. Wessman SJ, Levings RL (1999) Benefits and risks due to animal serum used in cell culture production. Dev. Biol. Stand. 99, 3-8.
11. Parker AM, Shang H, Khurgel M, Katz AJ (2007) Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy 9, 637-646.
12. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ et al. (2004) Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther. 9, 747-756.
13. Battiwalla M, Hematti P (2009) Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11, 503-515.
14. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E et al. (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436-1446.
15. Gottipamula S, Sharma A, Krishnamurthy S, Majumdar AS, Seetharam RN (2012) Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol. Lett. 34, 1367-1374.
16. Jayme DW, Smith SR (2000) Media formulation options and manufacturing process controls to safeguard against introduction of animal origin contaminants in animal cell culture. Cytotechnology 33, 27-36.
17. van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G et al. (2004) The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol. In Vitro 18, 1-12.
18. Dimarakis I, Levicar N (2006) Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24, 1407-1408.
19. Tekkatte C, Gunasingh GP, Cherian KM, Sankaranarayanan K (2011) "Humanized" stem cell culture techniques: the animal serum controversy. Stem Cells Int. 2011, 504723.
20. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23, 1357-1366.
21. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 99, 8932-8937.
22. Erickson GA, Bolin SR, Landgraf JG (1991) Viral contamination of fetal bovine serum used for tissue culture: risks and concerns. Dev. Biol. Stand. 75, 173-175.
23. Bieback K, Hecker A, Schlechter T, Hofmann I, Brousos N, Redmer T et al. (2012) Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy 14, 570-583.
24. Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U et al. (2007) N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197-202.
25. Gottipamula S, Muttigi MS, Chaansa S, Ashwin KM, Priya N, Kolkundkar U et al. (2013) Large-scale expansion of pre-isolated bone marrow mesenchymal stromal cells in serum-free conditions. J. Tissue Eng. Regen. Med. doi:10.1002/term.1713. (PMID:23495227)
26. Berger MG, Veyrat-Masson R, Rapatel C, Descamps S, Chassagne J, Boiret-Dupre N (2006) Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24, 2888-2890.
27. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24, 462-471.
28. Baba K, Yamazaki Y, Ishiguro M, Kumazawa K, Aoyagi K, Ikemoto S et al. (2013) Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived fibrin: a preliminary study. J. Craniomaxillofac. Surg. doi:10.1016/j.jcms.2013.01.025. [Epub ahead of print].
29. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D et al. (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27, 2331-2341.
30. Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC (2010) A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res. Ther. 1, 8.
31. Chase LG, Yang S, Zachar V, Yang Z, Lakshmipathy U, Bradford J et al. (2012) Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells. Stem Cells Transl. Med. 1, 750-758.
32. Hudson JE, Mills RJ, Frith JE, Brooke G, Jaramillo-Ferrada P, Wolvetang EJ et al. (2011) A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. Stem Cells Dev. 20, 77-87.
33. Jung S, Panchalingam KM, Rosenberg L, Behie LA (2012) Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int. 2012, 123030.
34. Jung S, Sen A, Rosenberg L, Behie LA (2010) Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 12, 637-657.
35. Jung S, Sen A, Rosenberg L, Behie LA (2011) Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum-free medium. J. Tissue Eng. Regen. Med. 6, 391-403.
36. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64, 295-312.
37. Mimura S, Kimura N, Hirata M, Tateyama D, Hayashida M, Umezawa A et al. (2011) Growth factor-defined culture medium for human mesenchymal stem cells. Int. J. Dev. Biol. 55, 181-187.
38. Kinzebach S, Bieback K (2012) Expansion of mesenchymal stem/stromal cells under xenogenic-free culture conditions. Adv. Biochem. Eng. Biotechnol. 129, 33-57.
39. De Luca A, Lamura L, Gallo M, Maffia V, Normanno N (2012) Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J. Cell. Biochem. 113, 3363-3370.
40. Jung J, Moon N, Ahn JY, Oh EJ, Kim M, Cho CS et al. (2009) Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev. 18, 559-571.
41. Bieback K, Schallmoser K, Kluter H, Strunk D (2008) Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfus. Med. Hemother. 35, 286-294.
42. Brunner D, Frank J, Appl H, Schoffl H, Pfaller W, Gstraunthaler G (2010) Serum-free cell culture: the serum-free media interactive online database. ALTEX 27, 53-62.
43. Yao S, Chen S, Clark J, Hao E, Beattie GM, Hayek A et al. (2006) Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. USA 103, 6907-6912.
44. Chen Y, Stevens B, Chang J, Milbrandt J, Barres BA, Hell JW (2008) NS21: re-defined and modified supplement B27 for neuronal cultures. J. Neurosci. Methods 171, 239-247.
45. Hatlapatka T, Moretti P, Lavrentieva A, Hass R, Marquardt N, Jacobs R et al. (2011) Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng. Part C Methods 17, 485-493.
46. Tateishi K, Ando W, Higuchi C, Hart DA, Hashimoto J, Nakata K et al. (2008) Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transplant. 17, 549-557.
47. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24, 1409-1410.
48. Kocaoemer A, Kern S, Kluter H, Bieback K (2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25, 1270-1278.
49. Dahl JA, Duggal S, Coulston N, Millar D, Melki J, Shahdadfar A et al. (2008) Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int. J. Dev. Biol. 52, 1033-1042.
50. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H et al. (2008) Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 58, 501-510.
51. Nimura A, Muneta T, Otabe K, Koga H, Ju YJ, Mochizuki T et al. (2011) Analysis of human synovial and bone marrow mesenchymal stem cells in relation to heat-inactivation of autologous and fetal bovine serums. BMC Musculoskeletal Disord. 11, 208.
52. Duggal S, Brinchmann JE (2011) Importance of serum source for the in vitro replicative senescence of human bone marrow derived mesenchymal stem cells. J. Cell. Physiol. 226, 2908-2915.
53. Patrikoski M, Juntunen M, Boucher S, Campbell A, Vemuri MC, Mannerstrom B et al. (2013) Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells. Stem Cell Res. Ther. 4, 27.
54. Venugopal P, Balasubramanian S, Majumdar AS, Ta M (2011) Isolation, characterization, and gene expression analysis of Wharton's jelly-derived mesenchymal stem cells under xeno-free culture conditions. Stem Cells Cloning 4, 39-50.
55. Jenhani F, Durand V, Ben Azouna N, Thallet S, Ben Othmen T, Bejaoui M et al. (2011) Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transpl. Proc. 43, 639-643.
56. Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, Koch C et al. (2011) Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant. 20, 1409-1422.
57. Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A et al. (2007) Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 40, 785-791.
58. Crespo-Diaz R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J et al. (2011) Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant. 20, 797-811.
59. Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G et al. (2007) Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen. Med. 2, 371-382.
60. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C et al. (2008) Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng. Part C Methods 14, 185-196.
61. Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F et al. (2009) Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 94, 1649-1660.
62. Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E et al. (2012) Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res. Ther. 3, 6.
63. Lohmann M, Walenda G, Hemeda H, Joussen S, Drescher W, Jockenhoevel S et al. (2012) Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One 7, e37839.
64. Walenda G, Hemeda H, Schneider RK, Merkel R, Hoffmann B, Wagner W (2012) Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells. Tissue Eng. Part C Methods 18, 924-934.
65. Warnke PH, Humpe A, Strunk D, Stephens S, Warnke F, Wiltfang J et al. (2013) A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J. Craniomaxillofac. Surg. 41, 153-161.
66. Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C et al. (2010) Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12, 888-898.
67. Shih DT, Chen JC, Chen WY, Kuo YP, Su CY, Burnouf T (2010) Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 51, 770-778.
68. Abdelrazik H, Spaggiari GM, Chiossone L, Moretta L (2011) Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur. J. Immunol. 41, 3281-3290.
69. Flemming A, Schallmoser K, Strunk D, Stolk M, Volk HD, Seifert M (2011) Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate. J. Clin. Immunol. 31, 1143-1156.
70. Kazemnejad S, Allameh A, Gharehbaghian A, Soleimani M, Amirizadeh N, Jazayeri M (2008) Efficient replacing of fetal bovine serum with human platelet releasate during propagation and differentiation of human bone-marrow-derived mesenchymal stem cells to functional hepatocyte-like cells. Vox Sang. 95, 149-158.
71. Jayme DW, Blackman KE (1985) Culture media for propagation of mammalian cells, viruses, and other biologicals. Adv. Biotechnol. Process 5, 1-30.
72. Jordan M, Voisard D, Berthoud A, Tercier L, Kleuser B, Baer G et al. (2013) Cell culture medium improvement by rigorous shuffling of components using media blending. Cytotechnology 65, 31-40.
73. Haack-Sorensen M, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J (2008) Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand. J. Clin. Lab. Invest. 68, 192-203.
74. Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI (1995) A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp. Cell Res. 219, 211-222.
75. Rajala K, Lindroos B, Hussein SM, Lappalainen RS, Pekkanen-Mattila M, Inzunza J et al. (2010) A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 5, e10246.
76. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109, 337-346.
77. Wu W, Zhou Y, Tan W (2009) In vitro culture of bone marrow-derived mesenchymal stem cells in a chemically-defined serum-free medium. Sheng Wu Gong Cheng Xue Bao 25, 121-128.
78. Gronthos S, Simmons PJ (1995) The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85, 929-940.
79. Marshak DR, Holecek JJ (1999) Chemically defined medium for human mesenchymal stem cells. Google Patents United States Patent 5, 908, 782.
80. Liu C-H, Wu M-L, Hwang S-M (2007) Optimization of serum free medium for cord blood mesenchymal stem cells. Biochem. Eng. J. 33, 1-9.
81. Tarle SA, Shi S, Kaigler D (2010) Development of a serum-free system to expand dental-derived stem cells: PDLSCs and SHEDs. J. Cell. Physiol. 226, 66-73.
82. Rajaraman G, White J, Tan KS, Ulrich D, Rosamilia A, Werkmeister J et al. (2013) Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application. Tissue Eng. Part C Methods 19, 80-92.
83. Kim EJ, Kim NS, Lee GM (1998) Development of a serum-free medium for the production of humanized antibody from Chinese hamster ovary cells using a statistical design. In Vitro Cell. Dev. Biol. Anim. 34, 757-761.
84. Kim EJ, Kim NS, Lee GM (1999) Development of a serum-free medium for dihydrofolate reductase-deficient Chinese hamster ovary cells (DG44) using a statistical design: beneficial effect of weaning of cells. In Vitro Cell. Dev. Biol. Anim. 35, 178-182.
85. Lee GM, Kim EJ, Kim NS, Yoon SK, Ahn YH, Song JY (1999) Development of a serum-free medium for the production of erythropoietin by suspension culture of recombinant Chinese hamster ovary cells using a statistical design. J. Biotechnol. 69, 85-93.
86. Castro PM, Hayter PM, Ison AP, Bull AT (1992) Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells. Appl. Microbiol. Biotechnol. 38, 84-90.
87. Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A (2010) Cell culture processes for monoclonal antibody production. MAbs. 2, 466-479.
88. Meng G, Liu S, Rancourt DE (2012) Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions. Stem Cells Dev. 21, 2036-2048.
89. Bray LJ, George KA, Hutmacher DW, Chirila TV, Harkin DG (2012) A dual-layer silk fibroin scaffold for reconstructing the human corneal limbus. Biomaterials 33, 3529-3538.
90. Bray LJ, Heazlewood CF, Atkinson K, Hutmacher DW, Harkin DG (2012) Evaluation of methods for cultivating limbal mesenchymal stromal cells. Cytotherapy 14, 936-947.
91. Miwa H, Hashimoto Y, Tensho K, Wakitani S, Takagi M (2011) Xeno-free proliferation of human bone marrow mesenchymal stem cells. Cytotechnology 64, 301-308.
92. Pal R, Hanwate M, Jan M, Totey S (2009) Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 3, 163-174.
93. Wagey R, Short B (2012) Isolation, enumeration, and expansion of human mesenchymal stem cells in culture. Methods Mol. Biol. 946, 315-334.
94. Yang T, Chen GH, Xue SL, Qiao M, Liu HW, Tian H et al. (2012) Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells. Zhonghua Xue Ye Xue Za Zhi 33, 715-719.
95. Yu J, Chau KF, Vodyanik MA, Jiang J, Jiang Y (2011) Efficient feeder-free episomal reprogramming with small molecules. PLoS One 6, e17557.
96. McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ (2004) Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6, 311-317.
97. Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC et al. (2012) Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system. BMC Biotechnol. 12, 18.
98. Agata H, Watanabe N, Ishii Y, Kubo N, Ohshima S, Yamazaki M et al. (2009) Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochem. Biophys. Res. Commun. 382, 353-358.
99. Hartmann I, Hollweck T, Haffner S, Krebs M, Meiser B, Reichart B et al. (2010) Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J. Immunol. Methods 363, 80-89.
100. Lindroos B, Boucher S, Chase L, Kuokkanen H, Huhtala H, Haataja R et al. (2009) Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy 11, 958-972.
101. Santos F, Andrade PZ, Abecasis MM, Gimble JM, Chase LG, Campbell AM et al. (2011) Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng. Part C Methods 17, 1201-1210.
102. Yang S, Pilgaard L, Chase LG, Boucher S, Vemuri MC, Fink T et al. (2012) Defined xenogeneic-free and hypoxic environment provides superior conditions for long-term expansion of human adipose-derived stem cells. Tissue Eng. Part C Methods 18, 593-602.
103. Sawada R, Yamada T, Tsuchiya T, Matsuoka A (2010) Microarray analysis of the effects of serum-free medium on gene expression changes in human mesenchymal stem cells during the in vitro culture. Yakugaku Zasshi 130, 1387-1393.
104. Ishikawa I, Sawada R, Kato Y, Tsuji K, Shao J, Yamada T et al. (2009) Effectivity of the novel serum-free medium STK2 for proliferating human mesenchymal stem cells. Yakugaku Zasshi 129, 381-384.
105. Meuleman N, Tondreau T, Delforge A, Dejeneffe M, Massy M, Libertalis M et al. (2006) Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur. J. Haematol. 76, 309-316.
106. Bieback K, Kern S, Kluter H, Eichler H (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625-634.
107. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S et al. (2007) Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75, 279-291.
108. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U et al. (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112, 295-307.
109. Apel A, Groth A, Schlesinger S, Bruns H, Schemmer P, Buchler MW et al. (2009) Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Exp. Cell Res. 315, 498-507.
110. Crapnell K, Blaesius R, Hastings A, Lennon DP, Caplan AI, Bruder SP (2013) Growth, differentiation capacity, and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp. Cell Res. 319, 1409-1418.
111. Fink T, Rasmussen JG, Lund P, Pilgaard L, Soballe K, Zachar V (2011) Isolation and expansion of adipose-derived stem cells for tissue engineering. Front. Biosci. (Elite Ed.) 3, 256-263.